pISSN 1225-7117
eISSN 2288-8268
Price Comparison With Herceptin And Biosimilar Owned Companies
| Company | Cost | |
|---|---|---|
| Herceptin | Roche | 600 mg/vial 987,366 won |
| Ogivri | Changing its monopoly to Daewoong Pharmaceutical, but voluntarily withdrew | 150 mg/vial 283,553 won |
| Herzuma | Celltrion | 440 mg/vial 893,531 won |
| Ontruzant | Samsung bioepis | 150 mg/vial 1,325 dollars |
| 420 mg/vial 3,709 dollars | ||
| Trazimera | Pfizer | 150 mg/vial 1,285 dollars |
| Kanjinti | Amgen | 420 mg/vial 3,697 dollars |